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Abstract (60 Words) 
 Early events of dengue virus (DENV) infection remain poorly understood. In this issue, 
Schaeffer and colleagues utilise ex vivo human skin cells to investigate viral infection. They show that 
skin-resident immune cells are infected by DENV and their infectability is increased in the 
inflammatory conditions - particularly where IL-4 is released - that accompany mosquito bites that 
transmit the virus. 
 
Body Text (1187 words) 
 Dengue virus (DENV) is a single-strand positive RNA virus and is the most common 
arthropod-transmitted virus (arbovirus), being transmitted to humans exclusively via Aedes 
mosquitos. Viral infection presents most commonly with fever, muscle/joint pains and headache 
that are often accompanied by a characteristic rash. More serious infection can progress to 
haemorrhagic dengue fever or dengue shock syndrome which can lead to death via haemorrhage 
and hypovolemic shock respectively. Neither vaccines nor specific antiviral treatments are available 
and the WHO estiŵates that alŵost half of the ǁorld’s populatioŶ are ĐurreŶtlǇ at risk. The potential 
severity of symptoms, significant at-risk population and lack of effective treatments have led to 
dengue disease being named as one of Bill and Melinda Gates FouŶdatioŶ’s neglected tropical 
diseases requiring increased research to improve global health. In the search for new 
treatment/prevention strategies, improved understanding of the viral pathogenesis is essential. The 
study by Schaeffer et al. (2014) in this issue utilises an ex vivo human skin cell model to further the 
understanding of DENV infection. 
 As DENV is transmitted via mosquito bites, skin is the primary site of infection. Human skin 
contains a variety of immunological cells including Langerhans cells (LCs) in the epidermis and 
subsets of dermal dendritic cells (DCs) along with macrophages and T-cells in the dermis. These cells 
will be amongst the first to encounter the virus following transmission. These heterogeneous cell 
populations present a challenge to studying immune responses to the virus in skin. Both LCs and DCs 
have previously been shown to be infected by DENV (Cerny et al., 2014). In their study, Schaeffer et 
al. (2014) investigated the interactions between DENV and dermal DCs and macrophages in normal 
conditions and in a model of inflammatory conditions. Dermal DCs, unlike LCs, are a heterogeneous 







(Chu et al., 2012 and Haniffa et al., 2012). Each subset possesses individual properties in terms of 





 DCs alongside dermal macrophages to elucidate the infectability of immune 
cells following viral entry to the skin. 
 C-type lectins such as Langerin (CD207), DC-SIGN (CD209) and mannose receptor 
(MR/CD206) enable immunological cells to uptake antigen from the extracellular environment 
(Engering et al., 2002 and de Witte et al., 2007). This uptake method is exploited by a number of 
viruses such as HIV-1 and DENV to gain entry into the cell, which they can subsequently infect 
(Arrighi et al., 2004). The role of DC-SIGN in DENV pathogenesis has been confirmed through the 
study of patients with certain DC-SIGN polymorphisms possessing a higher risk of developing dengue 
haemorrhagic fever following viral infection (Sakuntabhai et al., 2005). 
 Given the proposed role of DC-SIGN in DENV infection, Schaeffer et al (2014) initially 
determined the effect of skin inflammation on the number of DC-SIGN
+
 cells, using bullous 
pemphigoid, hypereosinophilic syndrome, mastocytosis and scabies infection affected skin as 
models for mosquito-bitten skin based on shared properties of basophil recruitment and 
eosinophilia. It was found that all of the inflammatory conditions studied produced increased the 
numbers of DC-SIGN
+
 cells in skin, when compared against non-diseased tissue, leading the authors 
to suggest that the inflammation arising from a mosquito bite might lead to the recruitment of 
infectable cells to the site. 
 Schaeffer et al. (2014) obtained skin DCs (along with other migratory cells) using a well-
established migratory cell protocol (Chu et al., 2012). Cells were infected in an unsorted state, then 
the infection levels determined post-infection via flow cytometry. They found that all of the studied 
skin DC subsets could be infected by DENV, with infectability being highest in CD14
+
 dermal DCs and 
lowest in LCs, with higher DC-SIGN expression in CD14
+
 cells suggested as a potential reason for this 
difference. The low infectability of LCs found by Schaeffer et al. (2014) contradicts previously 
reported results that found LCs were the most susceptible skin immune cell to DENV infection (Cerny 
et al., 2014). 
 Transmission of arboviruses is accompanied by trauma to the local site as well as delivery of 
insect salivary substances, which can elicit an immune response in isolation. It is speculated that the 
Th2-type immune response that occurs following insect bite leads to an increase in infection and 
clinical symptoms from DENV (Cox et al., 2012). Schaeffer et al (2014) focussed on interleukin-4 (IL-
4), which is released from basophils, mast cells and T-cells during the immune response to foreign 
antigen, to determine whether inflammation from the mosquito bite promotes viral infection of skin 
immune cells. Exposing the DCs to IL-4 led to a marked increase in CD14
+
 DC infection with the virus 
with little effect on other DCs/LCs, suggesting CD14
+
 cell infection may become prominent following 
mosquito bite inflammation. Incubation of dermal DCs with IL-4 also enhanced their T-cell 
stimulatory ability as evidenced by proliferation of CFSE-labelled naïve T-cells following co-culture. 
Their presence in the skin and expression of the C-type lectin MR make macrophages a potential 
DENV-infectable cell population. Dermal macrophage infection was studied following enzymatic 
digestion of skin and cell sorting. This allowed them to obtain a population of CD14
+
 macrophages - 
the authors speculate that CD14
+
 DCs may have developed a macrophage-like phenotype in culture. 
It was found that IL-4 with or without GM-CSF also increased DENV infection. Infection led to release 
of TNF-α, ŵost ŵarkedlǇ iŶ ŵaĐrophages ǁith higher iŶfeĐtioŶ leǀels. This led the authors to 
speculate that DENV infection of DCs would lead to potent T-cell antiviral responses whereas 
macrophage infection would most likely lead to the inflammatory symptoms associated with DENV 
infection. 
 Schaeffer et al. (2014) reason that since CD14
+
 DCs are most readily infected, especially 
under inflammatory conditions, and since they tend to produce humoral immune responses, these 
cells are likely to be responsible for the increased severity of DENV disease on subsequent exposure 
to a different serotype of the virus. This occurs due to cross-reactive antibodies that can bind to 
other DENV serotypes without fully neutralising them, instead facilitating their entry into immune 
cells and leading to more severe infection (Endy et al., 2004). This could represent an important 
target for further study as moderating this response might be able to lower the risk of serious DENV 
disease developing. The release of TNF-α ďǇ ŵaĐrophages iŶ the derŵis, espeĐiallǇ ǁheŶ eǆposed to 
IL-4, is also likely to be iŵportaŶt due to the ĐǇtokiŶe’s proposed central role in the development of 
dengue fever. It is also likely that the local inflammation brought about by TNF-α release ǁould lead 
to the release of IL-4, creating a cycle of increasing infectability of the local immune cells.  
 Schaeffer et al’s (2014) study therefore builds upon previous animal studies that have shown 
an increase in arbovirus infection due to the immune response to mosquito salivary substances and 
provides novel data utilising primary human skin cells, which will much more closely resemble the in 
vivo infection situation. Understanding how DENV can take advantage of inflammatory conditions 
for its propagation may highlight novel opportunities to block this virus when it tries to invade the 
host via skin immune cells.  
 
Clinical Implications 
 Aedes mosquito bites lead to local inflammation, which results in release of IL-4. This 
cytokine increases the infectability of both dermal dendritic cells and dermal macrophages.  CD14+ DCs are the most readily infected cells and are likely to be important in driving 
humoral immune responses against DENV.  Dermal macrophages release TNF-α upoŶ DENV iŶfeĐtioŶ, driǀiŶg loĐal iŶflaŵŵatioŶ aŶd 
further increasing the infectability of skin immune cells. 
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